Prasanth Srinivasan

Employment

• Cancer Institute (WIA) Assistant Professor
  2022 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• Treatment Outcomes of Pediatric Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Real World Evidence from a Tertiary Cancer Care Centre in Southern India
  Indian Journal of Hematology and Blood Transfusion 2026 DOI: 10.1007/s12288-026-02559-5
  +Save
• Dexamethasone-Free Antiemetic Prophylaxis for Children and Adolescents Receiving Highly Emetogenic Chemotherapy: A Multicenter, Phase III, Noninferiority Trial (CIVIC POD)
  Journal of Clinical Oncology 2026 DOI: 10.1200/JCO-26-00677
  +Save
• Fludarabine – Total Body Irradiation-Based Myeloablative Conditioning for Haploidentical Hematopoietic Stem Cell Transplantation: A 10-Year Single Centre Real-World Analysis
  Indian Journal of Hematology and Blood Transfusion 2026 DOI: 10.1007/s12288-025-02072-1
  +Save
• Cyclophosphamide and Topotecan in Relapsed and Refractory Pediatric Extracranial Solid Tumors: A Retrospective Analysis
  Indian Pediatrics 2026 DOI: 10.1007/s13312-025-00248-6
  +Save
• Autologous Stem Cell Transplantation for High-Risk Neuroblastoma - A Real-World Evidence from A Tertiary Cancer Care Center in Southern India
  Indian Journal of Hematology and Blood Transfusion 2026 DOI: 10.1007/s12288-025-02012-z
  +Save
• PREPARE ALL: An Artificial Intelligence Tool for Predicting Relapse in Children With Acute Lymphoblastic Leukemia
  JCO Clinical Cancer Informatics 2026 DOI: 10.1200/CCI-25-00222
  +Save
• Multidisciplinary Management of Children with Non-Wilms Renal Tumor: A Real-World Evidence from a Tertiary Cancer Care Center in Southern India
  Indian Journal of Medical and Paediatric Oncology 2025 DOI: 10.1055/s-0045-1813008
  +Save
• Escalation and De-Escalation Strategy for Initiating Antibiotics in Patients with Pediatric Cancer: A Prospective Observational Study
  Indian Journal of Medical and Paediatric Oncology 2025 DOI: 10.1055/s-0045-1809990
  +Save